This pre-clinical study focuses on selected genetic, early neurodevelopmental and pharmacological animal models that capture the combined behavioral and metabolic abnormalities shown by schizophrenic patients.
New Results: First RCT for Schizophrenia & Bipolar Disorder. Learn more.